Effects of Ergotamine on Myocardial Blood Flow in Migraineurs Without Evidence of Atherosclerotic Coronary Artery Disease 1 1 The study was partly sponsored by Glaxo-Wellcome R&D, Greenford, United Kingdom.
Titel:
Effects of Ergotamine on Myocardial Blood Flow in Migraineurs Without Evidence of Atherosclerotic Coronary Artery Disease 1 1 The study was partly sponsored by Glaxo-Wellcome R&D, Greenford, United Kingdom.
Auteur:
Gnecchi-Ruscone MD, Tomaso Lorenzoni MD, Roberto Anderson MBBS, Duncan Legg FRCP, Nigel Tousoulis MD, Dimitri Winter MD, Paul D.O’B Crisp PhD, Adam Camici MD, Paolo G